Hippocampal glucose metabolism is associated with cerebrospinal fluid estrogen levels in postmenopausal women with Alzheimer's disease

Psychiatry Research - Neuroimaging

Volumn 124, Issue 2, 2003, Pages 125-127

  Schönknecht, Peter ^a   Henze, Marcus ^a   Hunt, Aoife ^a   Klinga, Klaus ^a   Haberkorn, Uwe ^a   Schröder, Johannes ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

17 estradiol; Alzheimer's disease; Hippocampus; Positron emission tomography

Indexed keywords

ESTRADIOL; ESTROGEN; FLUORODEOXYGLUCOSE; GLUCOSE;

ADULT; AGED; ALZHEIMER DISEASE; ANALYZER; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CEREBROSPINAL FLUID LEVEL; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; IMAGE PROCESSING; IMMUNOASSAY; MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; STATISTICS;

AGED; ALZHEIMER DISEASE; BLOOD GLUCOSE; DOMINANCE, CEREBRAL; ESTRADIOL; FEMALE; FLUORODEOXYGLUCOSE F18; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED; POSTMENOPAUSE; REFERENCE VALUES;

EID: 1642344700     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(03)00086-6     Document Type: Article

References (8)

1. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 12:1975;189-198.
2. Maki P.M., Resnick S.M. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. NeuroImage. 14:2001;789-801.
3. McKhann G., Drachman D., Folstein M., Katzman R. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 37:1984;939-944.
4. Ott B.R., Heindl W.C., Tan Z., Noto R.B. Lateralized cortical perfusion in woman with Alzheimer's disease. Journal of Gender-Specific Medicine. 3:2000;29-35.
5. Schönknecht P., Pantel J., Klinga K., Jensen M., Hartmann T., Salbach B., Schröder J. Reduced cerebrospinal fluid estradiol levels are associated with increased β-amyloid levels in female patients with Alzheimer's disease. Neuroscience Letters. 307:2001;122-124.
6. Schröder J., Buchsbaum M.S., Shihabuddin L., Tang C., Wei T., Spiegel-Cohen J., Hazlett E.A., Abel L., Luu-Hsia C., Ciaravolo T.M., Marin D., Davis K.L. Patterns of cortical activity and memory performance in Alzheimer's disease. Biological Psychiatry. 49:2001;426-436.
7. Talairach J., Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. Three-dimensional Proportional System: An Approach to Cerebral Imaging. 1988;Thieme Medical Publishers, Inc, New York. [Translated by M. Rayport].
8. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J.N., Seeger M., Relkin N.R., Liao F., Checler F., Buxbaum J.D., Chait B.T., Thinakaran G., Sisodia S.S., Wang R., Greengard P., Gandy S. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nature Medicine. 4:1998;447-451.